AXL and cancer: As c‐MYC has been shown to play a role in cancer therapy drug resistance (Li et al., 2014; Zhang et al., 2015), we investigated whether AXL‐dependent epirubicin resistance involves regulation of c‐MYC expression in EAC cells.